Hopfner Robert Lorne

CIK 00015519665 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001551966

Recent Transactions

50 trades

Purchase
Evommune, Inc.$EVMN
Common Stock
2025-12-19$17.35/sh+1,000→ 4,026 total
Conversion
Evommune, Inc.$EVMN
Common Stock
2025-11-07+1,441,032→ 1,441,032 total
Conversion
Evommune, Inc.$EVMN
Series Seed Preferred Stock
2025-11-07−3,572,816→ 0 total
Conversion
Evommune, Inc.$EVMN
Series Seed Preferred Stock
2025-11-07−25,790→ 0 total
Conversion
Evommune, Inc.$EVMN
Series Seed Preferred Stock
2025-11-07−7,145,647→ 0 total
Conversion
Evommune, Inc.$EVMN
Common Stock
2025-11-07+294,502→ 294,502 total
Conversion
Evommune, Inc.$EVMN
Series A Preferred Stock
2025-11-07−2,582,243→ 0 total
Conversion
Evommune, Inc.$EVMN
Common Stock
2025-11-07+1,632,441→ 1,632,441 total
Conversion
Evommune, Inc.$EVMN
Common Stock
2025-11-07+3,026→ 3,026 total
Conversion
Evommune, Inc.$EVMN
Series C Preferred Stock
2025-11-07−2,508,575→ 0 total
Conversion
Evommune, Inc.$EVMN
Series C Preferred Stock
2025-11-07−313,571→ 0 total
Conversion
Evommune, Inc.$EVMN
Series B Preferred Stock
2025-11-07−1,895,260→ 0 total
Conversion
Evommune, Inc.$EVMN
Series A Preferred Stock
2025-11-07−7,230,283→ 0 total
Conversion
Evommune, Inc.$EVMN
Series C Preferred Stock
2025-11-07−313,571→ 0 total
Conversion
Evommune, Inc.$EVMN
Series B Preferred Stock
2025-11-07−2,104,740→ 0 total
Disposition from Tender
Inozyme Pharma, Inc.
Common Stock
2025-07-01$4.00/sh−2,923,110→ 0 total
Disposition from Tender
Inozyme Pharma, Inc.
Common Stock
2025-07-01$4.00/sh−1,571,741→ 0 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2025-05-13+28,500→ 28,500 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2025-01-02$0.70/sh+73,571→ 73,571 total
Award
Inozyme Pharma, Inc.
Stock Option (right to buy)
2024-06-18+28,000→ 28,000 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2024-05-15+16,500→ 16,500 total
Purchase
Inozyme Pharma, Inc.
Common Stock
2023-08-01$4.80/sh+119,048→ 2,923,110 total
Purchase
Inozyme Pharma, Inc.
Common Stock
2023-08-01$4.80/sh+714,285→ 1,571,741 total
Award
Inozyme Pharma, Inc.
Stock Option (right to buy)
2023-06-13+16,000→ 16,000 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2023-05-17+15,490→ 15,490 total
Purchase
Inozyme Pharma, Inc.
Common Stock
2023-05-12$6.25/sh+228,702→ 3,661,518 total
Purchase
Inozyme Pharma, Inc.
Common Stock
2023-05-11$6.48/sh+219,230→ 3,432,816 total
Purchase
Inozyme Pharma, Inc.
Common Stock
2023-03-29$4.54/sh+344,592→ 3,213,586 total
Purchase
Inozyme Pharma, Inc.
Common Stock
2023-03-28$4.16/sh+156,766→ 2,868,994 total
Purchase
Inozyme Pharma, Inc.
Common Stock
2023-03-27$3.70/sh+51,074→ 2,712,228 total
Award
Inozyme Pharma, Inc.
Stock Option (Right to Buy)
2022-06-10+9,367→ 9,367 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2022-05-24+13,440→ 13,440 total
Purchase
Inozyme Pharma, Inc.
Common Stock
2022-04-19$3.69/sh+1,070,000→ 2,661,154 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2022-01-03+6,242→ 6,242 total
Purchase
Rallybio Corp$RLYB
Common Stock
2021-08-02$13.00/sh+576,923→ 2,267,411 total
Other
Rallybio Corp$RLYB
Common Stock
2021-07-28+1,694,388→ 1,694,388 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2021-07-28+13,440→ 13,440 total
Other
Rallybio Corp$RLYB
Series B Preferred Units
2021-07-28−10,789,193→ 0 total
Award
Inozyme Pharma, Inc.
Stock Option (right to buy)
2021-06-23+9,367→ 9,367 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2021-06-02−15,000→ 15,000 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2021-02-10$27.64/sh−7,567→ 1,412,050 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2021-02-10$25.75/sh−37,271→ 1,446,305 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2021-02-10$26.78/sh−26,688→ 1,419,617 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2021-02-10$28.66/sh−6,632→ 1,405,418 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2021-02-09$28.07/sh−88,756→ 1,577,316 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2021-02-09$28.75/sh−93,740→ 1,483,576 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2021-02-09$27.12/sh−38,248→ 1,666,072 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2021-02-08$25.64/sh−50,874→ 1,733,242 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2021-02-08$26.06/sh−28,922→ 1,704,320 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2021-02-03$25.06/sh−2,768→ 1,784,116 total

Companies

Recent Filings

Address

C/O HYPERION THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 200

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov